Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Vose

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Seminars in Hematology|October 26, 1999
Antibody-targeted therapy for low-grade lymphomaJ M Vose
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Classification and clinical course of low-grade non-Hodgkin's lymphomas with overview of therapyJ M Vose
The New England Journal of Medicine|December 7, 1995
Treatment for non-Hodgkin's lymphoma in relapse. What are the alternatives?J M Vose
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 1998
High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphomaJ M Vose
Cytotherapy|June 5, 2002
Therapeutic uses of MAbs directed against CD20J M Vose
Seminars in Oncology|April 1, 1995
Chemotherapeutic palliative approaches in the treatment of lymphomaJ M Vose
Seminars in Oncology|February 1, 1995
Cytokine use in the older patientJ M Vose
Seminars in Oncology|September 5, 1998
Current approaches to the management of non-Hodgkin's lymphomaJ M Vose
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2008
Update on T-cell lymphomaJ M Vose
Oncology (Williston Park, N.Y.)|March 17, 2001
Immunotherapy for non-Hodgkin's lymphomaJ M Vose
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Seminars in Hematology|October 26, 1999
Antibody-targeted therapy for low-grade lymphomaJ M Vose
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Classification and clinical course of low-grade non-Hodgkin's lymphomas with overview of therapyJ M Vose
The New England Journal of Medicine|December 7, 1995
Treatment for non-Hodgkin's lymphoma in relapse. What are the alternatives?J M Vose
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 1998
High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphomaJ M Vose
Cytotherapy|June 5, 2002
Therapeutic uses of MAbs directed against CD20J M Vose
Seminars in Oncology|April 1, 1995
Chemotherapeutic palliative approaches in the treatment of lymphomaJ M Vose
Seminars in Oncology|February 1, 1995
Cytokine use in the older patientJ M Vose
Seminars in Oncology|September 5, 1998
Current approaches to the management of non-Hodgkin's lymphomaJ M Vose
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2008
Update on T-cell lymphomaJ M Vose
Oncology (Williston Park, N.Y.)|March 17, 2001
Immunotherapy for non-Hodgkin's lymphomaJ M Vose
Pageof 14